Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Nuclear Cardiology
Published in: Journal of Nuclear Cardiology 1/2001

01-01-2001

Copper-62-pyruvaldehyde bis(N4-methyl-thiosemicarbazone) PET imaging in the detection of coronary artery disease in humans

Authors: Thomas R. Wallhaus, Jeffrey Lacy, Richard Stewart, Jesus Bianco, Mark A. Green, Nisha Nayak, Charles K. Stone

Published in: Journal of Nuclear Cardiology | Issue 1/2001

Login to get access
Metadata
Title
Copper-62-pyruvaldehyde bis(N4-methyl-thiosemicarbazone) PET imaging in the detection of coronary artery disease in humans
Authors
Thomas R. Wallhaus
Jeffrey Lacy
Richard Stewart
Jesus Bianco
Mark A. Green
Nisha Nayak
Charles K. Stone
Publication date
01-01-2001
Publisher
Springer-Verlag
Published in
Journal of Nuclear Cardiology / Issue 1/2001
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1067/mnc.2001.109929

Other articles of this Issue 1/2001

Journal of Nuclear Cardiology 1/2001 Go to the issue

Editorial

The MIBG tarot: Is it possible to predict the efficacy of β-blockers in congestive heart failure?

OriginalPaper

Comparison of left ventricular function at rest and post-stress in patients with myocardial infarction: Evaluation with gated SPECT

OriginalPaper

Dobutamine stress electrocardiography-gated Tc-99m tetrofosmin SPECT for detection of viable but dysfunctional myocardium

Original Articles

Iodine-123 MIBG imaging before treatment of heart failure with carvedilol to predict improvement of left ventricular function and exercise capacity

OriginalPaper

Functional, structural, and genetic mitochondrial abnormalities in myocardial diseases

OriginalPaper

Interhospital observer agreement in interpretation of exercise myocardial Tc-99m tetrofosmin SPECT studies

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits